Antioxidant ·Emerging evidence ·Reviewed May 2026
Ergothioneine is a naturally occurring sulfur-containing amino acid derivative (a betaine of 2-mercaptohistidine) synthesized by fungi and certain bacteria but not by humans, who must obtain it from the diet. It is taken up and concentrated in cells via a dedicated transporter (OCTN1/SLC22A4), accumulating in tissues with high oxidative load such as mitochondria, liver, kidney, red blood cells and the lens of the eye. Because of its selective retention and stability, it has been proposed as a diet-derived cytoprotective compound, sometimes informally called a 'longevity vitamin.'
The bottom line
Evidence rating emerging. Most-documented uses: may reduce oxidative stress and protect cells from free-radical damage, associated in observational data with healthier aging and lower risk of cardiometabolic disease, may support mitochondrial protection. 10 sources indexed (2005–2020), with 4 interaction records on file.
Core mechanism
Ergothioneine exists predominantly in its stable thione tautomer at physiological pH, which makes it resistant to autoxidation and gives it a long intracellular half-life compared with other thiols such as glutathione. It is actively imported into cells by the organic cation transporter novel type 1 (OCTN1, encoded by SLC22A4), allowing it to concentrate in specific tissues and subcellular compartments including mitochondria. Functionally it scavenges reactive oxygen and nitrogen species (including hydroxyl radical, peroxynitrite and singlet oxygen), chelates divalent transition metals such as copper that would otherwise catalyze oxidative reactions, and helps maintain cellular redox balance. These actions are associated with reduced lipid peroxidation, protection of mitochondrial function, and dampening of inflammatory signaling, though the precise downstream pathways in humans remain under investigation.7,1
Water soluble and absorbed via the OCTN1 transporter in the intestine; tissue uptake is transporter-mediated and slow, so it accumulates over weeks of regular intake rather than acting acutely. Can be taken with or without food.1
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes L-Ergothioneine (purified, 5-15 mg per serving).
Ergothioneine is one of the more expensive antioxidants because purified material is costly to produce; budget options are usually lower-dose mushroom extracts, while branded fermentation-derived grades sit at the premium end. Prices reflect typical US retail per effective daily dose of 5-15 mg. Whole-food mushroom sources are cheaper per gram of mushroom but deliver smaller, more variable ergothioneine amounts. Updated 2026-06-04.
Timing: Once daily, any time of day, with or without food
Lower blood ergothioneine has been associated with higher cardiovascular and all-cause mortality in observational cohorts, which underpins the 'longevity vitamin' framing. Causation in humans is not established, so this is a plausible-but-unproven longevity use. Because it accumulates and is retained for weeks, daily dosing builds steady tissue levels rather than producing acute effects.
Timing: Once daily; consistent daily use matters more than timing because of tissue accumulation
Ergothioneine concentrates in mitochondria and other compartments exposed to oxidative stress, where it scavenges reactive oxygen species and chelates metals. Doses up to 25-30 mg/day have been used in trials and are well tolerated; higher doses raise blood and tissue levels further but added clinical benefit is unproven.
Dose: 5-25 mg daily
Timing: Once daily, morning is convenient but not required
OCTN1 transporters are present at the blood-brain barrier and in neural tissue, and lower ergothioneine status has been linked to mild cognitive impairment and frailty in older adults. Evidence is preliminary and largely observational; benefit for cognition in healthy people is not established.
What to test, the optimal window inside the conventional range, and how long a response takes.
Supplementation and higher dietary intake (especially mushrooms) raise whole-blood and plasma ergothioneine; levels tend to decline with advancing age and in some chronic diseases.1,2
Measured by LC-MS/MS, mainly in research settings; not a routine clinical test. Whole blood is preferred because ergothioneine concentrates in erythrocytes. Levels are strongly influenced by recent diet, so timing relative to mushroom intake and supplementation matters. Genetic variants in SLC22A4 (OCTN1) affect transport and baseline levels.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Ergothioneine is concentrated in neural tissue via the OCTN1 (SLC22A4) transporter and acts as a cytoprotective antioxidant, scavenging reactive oxygen species and chelating divalent metal ions; lower plasma levels have been associated in observational cohorts with worse cognitive performance and higher dementia risk, but a direct symptomatic benefit in humans has not been demonstrated in controlled trials.6,7
Evidence is largely associative (epidemiology and preclinical models). No robust randomized trial shows ergothioneine clears subjective cognitive fog. Treat as speculative, not a treatment.
Declining blood ergothioneine with age correlates with frailty and cognitive impairment in cohort studies; mechanistically it accumulates in mitochondria and may limit oxidative damage and neuroinflammation, processes implicated in neurodegeneration. Causality is unproven.1,8
Promising biomarker associations only. Human interventional data on memory outcomes are lacking; do not present as protective against dementia.
Ergothioneine accumulates in inflammatory cells via OCTN1 and has shown anti-inflammatory and antioxidant effects in preclinical models, scavenging reactive oxygen and nitrogen species and dampening cytokine release. Human data are limited to associations between higher dietary intake and lower inflammatory mortality.7,1
Preclinical and observational signals only. Not a substitute for treating an underlying inflammatory condition.
As a mitochondrially-accumulating antioxidant, ergothioneine may reduce oxidative stress that contributes to cellular fatigue; lower levels track with frailty in older adults. There is no direct trial evidence that supplementation raises energy or reduces tiredness.2,6
Mechanistically plausible but unsupported by human fatigue trials. Rule out anemia, thyroid, and sleep causes first.
Both compounds support cellular thiol-based antioxidant defenses. Ergothioneine is a stable, transporter-accumulated antioxidant, while N-acetylcysteine replenishes glutathione; their distinct mechanisms can be complementary.
Recommendation: Reasonable to combine for antioxidant support. No dose adjustment needed. Expect additive, not dramatic, effects and rely on data showing only modest, mostly preclinical benefit.
Vitamin C is an aqueous-phase antioxidant and can help regenerate other antioxidants, while ergothioneine provides stable intracellular and mitochondrial protection. The combination broadens antioxidant coverage across cellular compartments.
Recommendation: Safe to take together; no separation required. View any benefit as supportive rather than proven.
Both target mitochondrial function and oxidative stress through distinct routes, so co-supplementation may offer complementary mitochondrial antioxidant support.
Recommendation: Combining is reasonable for mitochondrial support; take CoQ10 with a fat-containing meal for absorption. No timing conflict with ergothioneine.
Green tea catechins and ergothioneine are both dietary antioxidants with anti-inflammatory activity that can act through complementary mechanisms.
Recommendation: Generally compatible. Be mindful of total catechin (EGCG) load from concentrated green tea extracts, which carries its own hepatotoxicity caution at high doses, independent of ergothioneine.
Numbered references. Citations throughout the page link here.
Oral ergothioneine was well absorbed and strongly retained in the body, with trends toward reduced biomarkers of oxidative stress and inflammation.
Argued that ergothioneine meets criteria for a longevity vitamin, with low body levels linked to accelerated aging phenotypes and chronic disease.
Reviewed evidence that ergothioneine accumulates in tissues exposed to oxidative stress and proposed it as a physiological cytoprotectant obtained from the diet.
In a prospective cohort, higher blood ergothioneine levels were associated with reduced risk of cardiovascular events and lower all-cause and cardiovascular mortality.
Identified OCTN1 as a high-affinity ergothioneine transporter, establishing a dedicated cellular uptake pathway and supporting a physiological function for dietary ergothioneine.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
